Intersect ENT is a leading medical technology company based in Edgewood, NY, dedicated to revolutionizing patient care for individuals suffering from chronic rhinosinusitis. They offer a range of integrated technologies that are minimally invasive and cost-effective, aiming to transform the treatment options available for millions of patients worldwide.
With a focus on innovation, Intersect ENT provides implants and delivery systems such as PROPEL and SINUVA, which may be covered by various patents in the United States and abroad. Committed to patient well-being, the company strives to improve the quality of life for those affected by chronic rhinosinusitis through their advanced medical solutions.
Generated from the website